NCT02062073View on ClinicalTrials.gov

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

PHASE1CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Head Lice
Interventions
DRUG

Abametapir Lotion 0.74% w/w

OTHER

0.1% sodium lauryl sulfate

OTHER

saline 0.9%

OTHER

Vehicle Lotion

Trial Locations (1)

07652

TKL Reserach, Paramus

Sponsors

Collaborators (1)

Accelovance
All Listed Sponsors
collaborator

TKL Research, Inc.

INDUSTRY

collaborator

Accelovance

INDUSTRY

lead

Dr. Reddy's Laboratories Limited

INDUSTRY

NCT02062073 - Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion | Biotech Hunter | Biotech Hunter